87530-30-1 Usage
Uses
Used in Pharmaceutical Industry:
7-Methoxy-9,10-dihydrophenanthrene-2,5-diol is used as a potential pharmaceutical agent for its various biological activities, such as antioxidant, anti-inflammatory, and cytotoxic effects. Its potential use in the treatment of cancer and other diseases makes it a promising candidate for further research and development.
Used in Anticancer Applications:
7-Methoxy-9,10-dihydrophenanthrene-2,5-diol is used as a potential anticancer agent due to its cytotoxic effects. It has been studied for its potential use in the treatment of various types of cancer, making it a promising compound for further research and development in the field of oncology.
Used in Drug Delivery Systems:
7-Methoxy-9,10-dihydrophenanthrene-2,5-diol can be used in drug delivery systems to improve the delivery, bioavailability, and therapeutic outcomes of the compound. Its potential use in various applications within the pharmaceutical industry highlights the need for further research and development in this area.
Check Digit Verification of cas no
The CAS Registry Mumber 87530-30-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,5,3 and 0 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 87530-30:
(7*8)+(6*7)+(5*5)+(4*3)+(3*0)+(2*3)+(1*0)=141
141 % 10 = 1
So 87530-30-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H14O3/c1-18-12-7-10-3-2-9-6-11(16)4-5-13(9)15(10)14(17)8-12/h4-8,16-17H,2-3H2,1H3
87530-30-1Relevant academic research and scientific papers
DIRECT AMPK ACTIVATOR COMPOUNDS
-
Page/Page column 46; 47; 48, (2019/12/25)
The present invention relates to a compound having general formula I for use in the activation of AMPK. A composition comprising said compound for use in the activation of AMPK is also provided. Said compounds are 9,10 dihydrophenanthrenes, in particular selected from the group consisting of: (i) Lusianthridin i.e. 7- Methoxy-9,10-dihydrophenanthrene-2,5-diol, (ii) 7-Methoxy-9,10- dihydrophenanthrene-2,3,5-triol, (iii) 9,10-dihydrophenanthrene-2,5- diol, (iv) 9,10-Dihydrophenanthrene-2,4,7-triol (v) 9,10-Dihydro-7- methoxy-3,5-phenanthrenediol, and the activation of AMPK improves the condition, disorder, or disease related to cardiometabolic health, obesity, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, and cancer.
